Physician
Mary Rutan Hospital
Mary Rutan Hospital was paid $3.88M by Medicaid between Jan 2018 and Dec 2024, across 81 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 47% of everything it billed.
33Billing provider infoMARY RUTAN HOSPITAL
BELLEFONTAINE, OH 43311
BELLEFONTAINE, OH 43311
33aNPI1891997169assigned 05/31/2007
33bProvider typeAllergy & Immunology Physician
28Total paid$3.88M
24GClaims125,196
24DCodes billed81
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Allergy & Immunology Physician providers in Ohio
Rank by total paid#2 of 33
Median peer was paid$78K
This provider vs. median50×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,428 | $352K | |
| 2019 | 13,835 | $331K | |
| 2020 | 17,020 | $557K | |
| 2021 | 18,964 | $626K | |
| 2022 | 19,990 | $657K | |
| 2023 | 20,450 | $627K | |
| 2024incomplete | 20,509 | $728K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 47% | 55,534 | 49,202 | $1.81M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 23% | 20,534 | 19,027 | $907K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 7.5% | 8,130 | 7,113 | $292K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 7.3% | 6,609 | 5,864 | $283K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.5% | 2,717 | 2,605 | $137K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.1% | 3,560 | 3,099 | $81K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1.8% | 10,639 | 7,639 | $68K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.6% | 1,619 | 1,543 | $60K |
| H1000 | Prenatal care, at-risk assessment | <1% | 244 | 199 | $23K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 352 | 332 | $21K |
| 59025 | Fetal non-stress test | <1% | 1,045 | 664 | $19K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 331 | 301 | $16K |
69 more codes
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 660 | $15K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 2,355 | $14K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 154 | $11K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 230 | $11K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 248 | $10K |
| 51798 | <1% | 1,066 | $8K | |
| 20610 | <1% | 240 | $8K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 113 | $7K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 47 | $6K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 561 | $6K |
| 69210 | <1% | 402 | $5K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 138 | $5K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 337 | $5K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 100 | $4K |
| 92557 | <1% | 108 | $3K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 256 | $3K |
| 0002A | <1% | 68 | $3K | |
| 0001A | <1% | 96 | $3K | |
| 99223 | Prolong inpt eval add15 m | <1% | 61 | $2K |
| 92567 | <1% | 227 | $2K | |
| 52000 | <1% | 65 | $2K | |
| 76830 | Ultrasound, transvaginal | <1% | 28 | $2K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 129 | $2K |
| 90686 | <1% | 1,027 | $2K | |
| 99220 | <1% | 42 | $2K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 24 | $1K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 43 | $1K |
| 90671 | <1% | 158 | $1K | |
| 90670 | <1% | 1,180 | $1K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 316 | $1K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 45 | $1K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 13 | $1K |
| 99217 | <1% | 52 | $982.24 | |
| 99460 | <1% | 12 | $941.64 | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 73 | $853.26 |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 13 | $789.81 |
| 95251 | <1% | 173 | $784.83 | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 17 | $773.60 |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allowed practitioner development and/or revision of care plans | <1% | 29 | $771.71 |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 12 | $438.24 |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 13 | $428.26 |
| 81003 | <1% | 329 | $380.17 | |
| 99443 | <1% | 12 | $364.23 | |
| 99305 | <1% | 25 | $320.58 | |
| 99442 | <1% | 13 | $266.22 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 22 | $244.35 |
| 0031A | <1% | 12 | $204.00 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 12 | $163.00 |
| 11721 | <1% | 12 | $147.18 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 368 | $145.46 |
| 87807 | <1% | 12 | $111.29 | |
| 85018 | <1% | 58 | $102.67 | |
| 96127 | <1% | 37 | $92.73 | |
| 87210 | <1% | 20 | $78.64 | |
| 99307 | <1% | 14 | $54.33 | |
| 90648 | <1% | 650 | $29.52 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 12 | $16.64 |
| 90647 | <1% | 117 | $10.00 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 23 | $3.21 |
| 91307 | <1% | 19 | $0.19 | |
| 91300 | <1% | 214 | $0.13 | |
| 91303 | <1% | 12 | $0.12 | |
| 90697 | 0% | 69 | $0.00 | |
| 90680 | 0% | 402 | $0.00 | |
| 90723 | 0% | 387 | $0.00 | |
| 90661 | 0% | 27 | $0.00 | |
| 90633 | 0% | 37 | $0.00 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 0% | 12 | $0.00 |
| 90707 | 0% | 24 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialROSS, CHAD (PRESIDENT/CEO)
Parent organizationMARY RUTAN HOSPITAL
| Provider | Location | Paid |
|---|---|---|
| Mary Rutan Hospital | Bellefontaine, OH | $15.79M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.